This digital document is an article from Skin & Allergy News, published by International Medical News Group on January 1, 2003. The length of the article is 433 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Interleukin-12 trials generate regression in CTCL. (Phase I and Phase II Trials).(cutaneous T-cell lymphomas)
Author: Diana Mahoney
Publication:Skin & Allergy News (Magazine/Journal)
Date: January 1, 2003
Publisher: International Medical News Group
Volume: 34 Issue: 1 Page: 36(2)
Distributed by Thomson Gale
Interleukin-12 trials generate regression in CTCL. (Phase I and Phase II Trials).(cutaneous T-cell lymphomas): An article from: Skin & Allergy News
📄 Viewing lite version
Full site ›
Book Details
Author(s)Diana Mahoney
PublisherInternational Medical News Group
ISBN / ASINB0008G5P3I
ISBN-13978B0008G5P34
AvailabilityAvailable for download now
Sales Rank12,411,452
MarketplaceUnited States 🇺🇸